Alnylam Pharmace. buy BMO Capital Markets
Start price
24.06.24
/
50%
€210.70
Target price
24.06.25
€218.11
Performance (%)
32.04%
End price
25.06.25
€278.20
Summary
This prediction ended on 25.06.25 with a price of €278.20. With a performance of 32.04% the BUY prediction by BMO_Capital_Markets was a big success. BMO_Capital_Markets has a follow-up prediction for Alnylam Pharmace. where he still thinks Alnylam Pharmace. is a Buy. BMO_Capital_Markets has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
AI-generated
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Alnylam Pharmace. | -0.279% | -0.279% | -50.089% |
| iShares Core DAX® | -1.059% | 5.007% | 6.596% |
| iShares Nasdaq 100 | -2.387% | 0.864% | 25.791% |
| iShares Nikkei 225® | -4.361% | 1.211% | 41.309% |
| iShares S&P 500 | -1.778% | 1.391% | 21.037% |
Comments by BMO_Capital_Markets for this prediction
In the thread Alnylam Pharmace. diskutieren
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) had its "outperform" rating re-affirmed by analysts at BMO Capital Markets. They now have a $234.00 price target on the stock.
Ratings data for ALNY provided by MarketBeat
In the thread Trading Alnylam Pharmace.
Die von BMO_Capital_Markets gewählte maximale Laufzeit wurde überschritten
Current prediction by BMO_Capital_Markets for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€386.00
05.09.25
05.09.25
€402.93
05.09.26
05.09.26
-49.12%
20.08.26
20.08.26
Stopped prediction by BMO_Capital_Markets for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€199.85
19.08.26
19.08.26
€274.72
19.08.27
19.08.27
-1.73%
20.08.26
20.08.26
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€279.80
24.06.25
24.06.25
€310.57
24.06.26
24.06.26
-8.86%
25.06.26
25.06.26
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€141.40
27.03.24
27.03.24
€216.31
27.03.25
27.03.25
74.96%
28.03.25
28.03.25